Artificial cilia for soft and stable surface covalent immobilization of bone morphogenetic protein-2

被引:8
|
作者
Gan, Qi [1 ,2 ]
Chen, Lina [1 ]
Bei, Ho-Pan
Ng, Sze-Wing [1 ]
Guo, Han [4 ]
Liu, Guoqiang [1 ]
Pan, Hao [2 ]
Liu, Changsheng [2 ]
Zhao, Xin [3 ]
Zheng, Zijian [1 ,5 ]
机构
[1] Hong Kong Polytech Univ, Sch Fash & Text, Lab Adv Interfacial Mat & Devices, Hong Kong Special Adm Reg China, Kowloon, Peoples R China
[2] East China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat Minist Educ, Shanghai 200237, Peoples R China
[3] Hong Kong Polytech Univ, Dept Biomed Engn, Hong Kong, Peoples R China
[4] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai Synchrotron Radiat Facil, Shanghai 201204, Peoples R China
[5] Hong Kong Polytech Univ, Fac Sci, Dept Appl Biol & Chem Technol, Hong Kong Special Adm Reg China, Kowloon, Peoples R China
基金
中国国家自然科学基金;
关键词
Polymer brush; Poly (glycidyl methacrylate); Surface modification; Protein immobilization; Bioactivity; TISSUE-REPAIR; BMP-2; REGENERATION; SCAFFOLDS;
D O I
10.1016/j.bioactmat.2022.12.029
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Preservation of growth factor sensitivity and bioactivity (e.g., bone morphogenetic protein-2 (BMP-2)) post-immobilization to tissue engineering scaffolds remains a great challenge. Here, we develop a stable and soft surface modification strategy to address this issue. BMP-2 (a model growth factor) is covalently immobilized onto homogeneous poly (glycidyl methacrylate) (PGMA) polymer brushes which are grafted onto substrate surfaces (Au, quartz glass, silica wafer, or common biomaterials) via surface-initiated atom transfer radical polymeri-zation. This surface modification method multiplies the functionalized interfacial area; it is simple, fast, gentle, and has little effect on the loaded protein owing to the cilia motility. The immobilized BMP-2 (i-BMP-2) on the surface of homogeneous PGMA polymer brushes exhibits excellent bioactivity (-87% bioactivity of free BMP-2 in vitro and 20%-50% higher than scaffolds with free BMP-2 in vivo), with conformation and secondary structure well-preserved after covalent immobilization and ethanol sterilization. Moreover, the osteogenic activity of i-BMP-2 on the nanoline pattern (PGMA-poly (N-isopropylacrylamide)) shows-110% bioactivity of free BMP-2. This is superior compared to conventional protein covalent immobilization strategies in terms of both bioactivity preservation and therapeutic efficacy. PGMA polymer brushes can be used to modify surfaces of different tissue-engineered scaffolds, which facilitates in situ immobilization of growth factors, and accelerates repair of a wide range of tissue types.
引用
收藏
页码:551 / 562
页数:12
相关论文
共 50 条
  • [31] The immobilization of bone morphogenetic protein-2 via photo curable azidophenyl hyaluronic acid on a titanium surface and providing effect for cell differentiation
    Hyung-Jae Lee
    Yun Heo
    Kyung-Tai Park
    Eun-Hye Kim
    Yoshihiro Ito
    Kwang-Sup Song
    Dong-Keun Han
    Tae-Il Son
    Macromolecular Research, 2014, 22 : 173 - 178
  • [32] Repair of bone allograft fracture using bone morphogenetic protein-2
    Lee, FYI
    Storer, S
    Hazan, EJ
    Gebhardt, MC
    Mankin, HJ
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2002, (397) : 119 - 126
  • [33] Response to Letter to Editor "Comment on 'Tuning the bioactivity of bone morphogenetic protein-2 with surface immobilization strategies' by Chen et al."
    Wang, Jing
    ACTA BIOMATERIALIA, 2019, 89 : 420 - 420
  • [34] BONE CELL INDUCTION BY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2
    ALPASLAN, C
    IRIE, K
    OHASHI, N
    SAKAI, H
    KENMOTSU, S
    TAKAHASHI, K
    EJIRI, S
    NAKAJIMA, T
    OZAWA, H
    JOURNAL OF DENTAL RESEARCH, 1995, 74 (03) : 971 - 971
  • [35] Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures
    Ghodadra, Neil
    Singh, Kern
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (03): : 345 - 354
  • [36] Experimental Study of Nano-Hydroxyapatite/Recombinant Human Bone Morphogenetic Protein-2 Composite Artificial Bone
    Zhu, Weimin
    Wang, Daping
    Zhang, Xiaojun
    Lu, Wei
    Han, Yun
    Ou, Yangkan
    Zhou, Ke
    Fen, Wenzhe
    Liu, Jianquan
    Peng, Liangquan
    He, Chunlei
    Zeng, Yanjun
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2010, 38 (03): : 150 - 156
  • [37] Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: Potential use of bone morphogenetic protein-2 for cartilage cell therapy
    Salentey, V.
    Claus, S.
    Bougault, C.
    Paumier, A.
    Aubert-Foucher, E.
    Perrier-Groult, E.
    Ronziere, M. -C.
    Freyria, A. -M.
    Galera, P.
    Beauchef, G.
    Duterque-Coquillaud, M.
    Piperno, M.
    Damour, O.
    Herbage, B.
    Mallein-Gerin, F.
    PATHOLOGIE BIOLOGIE, 2009, 57 (04): : 282 - 289
  • [38] Bone Morphogenetic Protein-2 Antagonizes Bone Morphogenetic Protein-4 Induced Cardiomyocyte Hypertrophy and Apoptosis
    Lu, Jing
    Sun, Bo
    Huo, Rong
    Wang, Yu-Chun
    Yang, Di
    Xing, Yue
    Xiao, Xiao-Lin
    Xie, Xin
    Dong, De-Li
    JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (10) : 1503 - 1510
  • [39] PERIODONTAL REGENERATION AND RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2
    KING, GN
    CRUCHLEY, AC
    HUGHES, FJ
    JOURNAL OF DENTAL RESEARCH, 1995, 74 : 592 - 592
  • [40] Accelerators of Osteogenesis by Recombinant Human Bone Morphogenetic Protein-2
    Okubo, Yasunori
    Kusumoto, Kenji
    Bessho, Kazuhisa
    DRUG TARGET INSIGHTS, 2007, 2 : 55 - 60